Related Experiment Video
Updated: Jul 10, 2026
Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
Published on: April 15, 2020
Role of NOD2/CARD15 in coronary heart disease
Nour Eddine El Mokhtari1, Stephan J Ott, Almut Nebel
1Department of Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany. elmokhtari@cardio.uni-kiel.de
Background:
Bacterial DNA has been repeatedly detected in atheromatous lesions of coronary heart disease (CHD) patients. Phylogenetic signatures in the atheroma lesions that are similar to those of bacterial biofilms on human barrier organs, including the respiratory or gastrointestinal tract, raise the question of a defective barrier function in CHD. NOD2 plays a major role in defense against bacterial invasion. Genetic variation in the CARD15 gene, which encodes NOD2, was previously shown to result in a barrier defect that causes chronic inflammatory disorders (e.g. Crohn disease). In the present study, we investigated the possible involvement of NOD2/CARD15 in the pathology of CHD by i) analyzing the local expression of NOD2 in atherectomy versus healthy tissue (n = 5 each) using histochemical immunofluorescence and ii) by testing the three major functional CARD15 variants (R702W, G908R and 1007fs) for association with early-onset CHD in 900 German patients and 632 healthy controls.
Results:
In atherectomy tissue of CHD patients, NOD2 was detected in inflammatory cells at the luminal sides of the lesions. However, the allele and genotype frequencies of the three major CARD15 polymorphisms did not differ between CHD patients and controls.
Conclusion:
The NOD2 up-regulation in atheroma lesions indicates an involvement of this protein in the pathology of CHD. Although NOD2 could be important in local immune response mechanisms, none of the analyzed CARD15 variants seem to play a significant role in the etiology of CHD.
Insights
NOD2 protein is present in coronary heart disease lesions, suggesting a role in the immune response. However, common genetic variations in CARD15 (encoding NOD2) are not associated with early-onset coronary heart disease.
Area of Science:
- Immunology
- Cardiovascular Disease Research
- Genetics
Background:
- Bacterial DNA is found in coronary heart disease (CHD) lesions.
- NOD2 (encoded by CARD15) is crucial for bacterial defense and its variants are linked to barrier defects.
- This study explores NOD2/CARD15 involvement in CHD pathology.
Purpose of the Study:
- To analyze NOD2 expression in CHD atheroma versus healthy tissue.
- To test for associations between major CARD15 variants and early-onset CHD.
Main Methods:
- Histochemical immunofluorescence for NOD2 detection in atherectomy and healthy tissues.
- Genotyping of three major CARD15 variants (R702W, G908R, 1007fs) in 900 CHD patients and 632 controls.
Main Results:
- NOD2 was detected in inflammatory cells within CHD atheroma tissue.
- No significant differences in allele or genotype frequencies of the studied CARD15 polymorphisms were found between CHD patients and controls.
Conclusions:
- NOD2 upregulation in atheroma suggests its involvement in CHD pathology and local immune responses.
- The analyzed CARD15 variants do not appear to be significant risk factors for the etiology of CHD.
Related Concept Videos
01:26Coronary Artery Disease II: Pathophysiology
01:30Coronary Artery Disease I: Introduction
01:26Coronary Artery Disease IV: Preventive Measures
01:30Coronary Artery Disease III: Clinical Manifestations
01:30Cardiomyopathy II: Dilated Cardiomyopathy
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations